Drug
AD109 clinical trials
Also written AD109.
- studies test it
- 6
- open now
- 0
- in phase 3
- 2
- first study started
- 2020
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
6 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 4
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Apnimed (6)
Often tested with
Tested in the same studies.
AD504 (1)
Studies
Open first, then newest update. How each study uses AD109 is read from its arms, and is right about nine times in ten.
Testing it · 6
- Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)CompletedPhase 3ApnimedNCT05813275Written as AD109
- Parallel Arm Trial of AD109 and AD504 In Patients With OSACompletedPhase 2ApnimedNCT05071612Written as AD109
- Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)CompletedPhase 3ApnimedNCT05811247Written as AD109
- Study That Tests AD109 in Patients Taking GLP-1 DrugsCompletedPhase 2ApnimedNCT06400615Written as AD109
- Crossover Trial of AD109 in Obstructive Sleep ApneaCompletedPhase 2ApnimedNCT04580394Written as AD109
- AD109 Dose Finding in Mild to Moderate OSACompletedPhase 2ApnimedNCT04631107Written as AD109 dose1- A